EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Fully Human Derived Monoclonal Antibody Provides Potent Pre‐ and Postexposure Protection Against Rabies Virus

Ruo Mo iD, Jingqi Xu iD, Huanqin Zheng iD, Tianyi Yin, Haiyang Cong iD, Lugong Chen iD, Feihu Yan, Na Feng, Tiecheng Wang, Jianzhong Wang iD, Yongkun Zhao iD, Xianzhu Xia iD

Transboundary and Emerging Diseases · 2026-01 · 2026 (1)

DOI: 10.1155/tbed/3021186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 19.06.2026. Verfasst von Ruo Mo und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jilin Agricultural University, Changchun, 130118, Jilin, China, jlau.edu.cn. Hauptthemen laut MEDLINE: Rabies, Rabies virus, Antibodies, Monoclonal, Post-Exposure Prophylaxis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rabies remains a critical global health concern, particularly in endemic regions where timely access to postexposure prophylaxis (PEP) is often limited. The effectiveness of PEP relies heavily on rabies immune globulin (RIG), yet plasma‐derived products continue to face persistent issues of limited supply, variable potency, and high cost. These constraints have intensified the demand for recombinant monoclonal antibodies (mAbs) that provide consistent quality and scalable production. Here, we describe the development of a fully human mAb, H81L90, directed against the rabies virus glycoprotein (RABV‐G). The antibody was isolated from a phage‐display library constructed using peripheral blood mononuclear cells (PBMCs) from vaccinated donors. H81L90 exhibited strong, specific binding to native RABV‐G with nanomolar affinity as determined by surface plasmon resonance (SPR) analysis. In cell‐based neutralization assays, H81L90 efficiently blocked infection by the ERA‐enhanced green fluorescent protein (EGFP) strain, achieving complete viral inhibition at low microgram concentrations. Protective efficacy was subsequently evaluated in a murine challenge model, where a single intramuscular injection of H81L90 conferred full survival when administered before or at the time of viral exposure and retained measurable activity at reduced doses postexposure. Histopathological assessment revealed substantially lower viral antigen in hippocampal tissue from treated animals, indicating suppression of early neuroinvasion. Collectively, these data establish H81L90 as a potent, fully human antibody with both preventive and postexposure prophylactic potential, supporting its continued development as a next‐generation biologic to complement or replace current RIG formulations in rabies PEP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RabiesRabies virusAntibodies, MonoclonalPost-Exposure ProphylaxisAntibodies, ViralAnimalsHumansMiceRabies VaccinesFemalePre-Exposure ProphylaxisMice, Inbred BALB C

Stichwörter der Autor:innen

monoclonal antibodyphage displayrabies

Substanzen

Antibodies, MonoclonalAntibodies, ViralRabies Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Jilin Agricultural University, Changchun, 130118, Jilin, China, jlau.edu.cn.
  • Key Laboratory of Jilin Province for Zoonoses Prevention and Control, State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Changchun, Jilin Province, China, bmi.ac.cn.

ORCID-Profile: Ruo Mo, Jingqi Xu, Huanqin Zheng, Haiyang Cong, Lugong Chen, Jianzhong Wang, Yongkun Zhao, Xianzhu Xia

Förderung

  • Jilin Scientific and Technological Development Program

Zitieren

APA

Mo, R., Xu, J., Zheng, H., Yin, T., Cong, H., Chen, L., Yan, F., Feng, N., Wang, T., Wang, J., Zhao, Y., & Xia, X. (2026). A Fully Human Derived Monoclonal Antibody Provides Potent Pre‐ and Postexposure Protection Against Rabies Virus. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/3021186

Vancouver

Mo R, Xu J, Zheng H, Yin T, Cong H, Chen L, et al. A Fully Human Derived Monoclonal Antibody Provides Potent Pre‐ and Postexposure Protection Against Rabies Virus. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/3021186

BibTeX
@article{Mo2026,
  author = {Mo, Ruo and Xu, Jingqi and Zheng, Huanqin and Yin, Tianyi and Cong, Haiyang and Chen, Lugong and Yan, Feihu and Feng, Na and Wang, Tiecheng and Wang, Jianzhong and Zhao, Yongkun and Xia, Xianzhu},
  title = {A Fully Human Derived Monoclonal Antibody Provides Potent Pre‐ and Postexposure Protection Against Rabies Virus},
  journal = {Transboundary and Emerging Diseases},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbed/3021186}
}
Kostenlos starten →